v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 16 $ 1,206,412 $ (891,084) $ 315,344
Balance, shares at Dec. 31, 2024 157,749,490      
Stockholders' Equity (Deficit)        
Issuance of common stock upon exercise of stock options   4,183   4,183
Issuance of common stock upon exercise of stock options, shares 880,115      
Issuance of common stock upon vesting of restricted stock units, shares 632,419      
Stock-based compensation expense   10,456   10,456
Net Income (Loss)     (64,053) (64,053)
Balance at Mar. 31, 2025 $ 16 1,221,051 (955,137) 265,930
Balance, shares at Mar. 31, 2025 159,262,024      
Balance at Dec. 31, 2025 $ 22 1,811,311 (1,157,023) 654,310
Balance, shares at Dec. 31, 2025 215,927,600      
Stockholders' Equity (Deficit)        
Issuance of common stock upon exercise of stock options   294   294
Issuance of common stock upon exercise of stock options, shares 50,379      
Issuance of common stock upon vesting of restricted stock units, shares 1,169,636      
Issuance of common stock upon exercise of pre-funded warrants, shares 1,749,300      
Stock-based compensation expense   15,582   15,582
Net Income (Loss)     (88,612) (88,612)
Balance at Mar. 31, 2026 $ 22 $ 1,827,187 $ (1,245,635) $ 581,574
Balance, shares at Mar. 31, 2026 218,896,915